首页>
外文期刊>Nanoscale
>Correction: All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation
【24h】
Correction: All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation
Correction for ‘All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation’ by Xiao-xiao Guo et al., Nanoscale, 2021, 13, 14525–14537, https://doi.org/10.1039/D1NR03869A.
展开▼
机译：修正的通用nanostrategy基于剂量增强沉积、细胞周期阻滞DNA损伤,ROS生产前列腺癌辐射敏化剂为潜在的临床“郭Xiao-xiao translation’et al .,纳米尺度,2021, 13, 14525–14537,https://doi.org/10.1039/D1NR03869A。
展开▼
